Stacey Rudd

Positron Emission Tomographic Imaging of Tumor Cell Death Using Zirconium-89-Labeled APOMAB (R) Following Cisplatin Chemotherapy in Lung and Ovarian Cancer Xenograft Models (Jul, 10.1007/s11307-021-01620-1, 2021)

Vasilios Liapis, William Tieu, Nicole L Wittwer, Tessa Gargett, Andreas Evdokiou, Prab Takhar, Stacey E Rudd, Paul S Donnelly, Michael P Brown, Alexander H Staudacher

Journal article  |  2021  |  MOLECULAR IMAGING AND BIOLOGY

This article was updated to amend the Acknowledgments.

Positron Emission Tomographic Imaging of Tumor Cell Death Using Zirconium-89-Labeled APOMAB (R) Following Cisplatin Chemotherapy in Lung and Ovarian Cancer Xenograft Models

Vasilios Liapis, William Tieu, Nicole L Wittwer, Tessa Gargett, Andreas Evdokiou, Prab Takhar, Stacey E Rudd, Paul S Donnelly, Michael P Brown, Alexander H Staudacher

Journal article  |  2021  |  MOLECULAR IMAGING AND BIOLOGY

PURPOSE: Early detection of tumor treatment responses represents an unmet clinical need with no approved noninvasive methods. DAB4..

Imaging Somatostatin Positive Tumors with Tyr(3)-Octreotate/Octreotide Conjugated to Desferrioxamine B Squaramide Radiolabeled with either Zirconium-89 or Gallium-68

Asif Noor, Jessica K Van Zuylekom, Stacey E Rudd, Peter D Roselt, Mohammad B Haskali, Eddie Yan, Michael Wheatcroft, Rodney J Hicks, Carleen Cullinane, Paul S Donnelly

Journal article  |  2021  |  BIOCONJUGATE CHEMISTRY

Radiolabeled derivatives of Tyr3-octreotide and Tyr3-octreotate, synthetic analogues of the peptide hormone somatostatin, can be u..

Enzyme mediated incorporation of zirconium-89 or copper-64 into a fragment antibody for same day imaging of epidermal growth factor receptor

Stacey E Rudd, Jessica K Van Zuylekom, Anna Raicevic, Lesley A Pearce, Carleen Cullinane, Charlotte C Williams, Timothy E Adams, Rodney J Hicks, Paul S Donnelly

Journal article  |  2021  |  CHEMICAL SCIENCE

Identification of tumors which over-express Epidermal Growth Factor Receptor (EGFR) is important in selecting patients for anti-EG..

Improved non-invasive positron emission tomographic imaging of chemotherapy-induced tumor cell death using Zirconium-89-labeled APOMAB (R)

Vasilios Liapis, William Tieu, Stacey E Rudd, Paul S Donnelly, Nicole L Wittwer, Michael P Brown, Alexander H Staudacher

Journal article  |  2020  |  EJNMMI RADIOPHARMACY AND CHEMISTRY

PURPOSE: The chimeric monoclonal antibody (mAb) chDAB4 (APOMAB®) targets the Lupus associated (La)/Sjögren Syndrome-B (SSB) antige..

Bivalent Inhibitors of Prostate-Specific Membrane Antigen Conjugated to Desferrioxamine B Squaramide Labeled with Zirconium-89 or Gallium-68 for Diagnostic Imaging of Prostate Cancer

Asif Noor, Jessica K Van Zuylekom, Stacey E Rudd, Kelly Waldeck, Peter D Roselt, Mohammad B Haskali, Michael P Wheatcroft, Eddie Yan, Rodney J Hicks, Carleen Cullinane, Paul S Donnelly

Journal article  |  2020  |  JOURNAL OF MEDICINAL CHEMISTRY

Prostate-specific membrane antigen (PSMA) is a carboxypeptidase that is overexpressed in prostate cancer and is an excellent candi..

Zirconium and copper immunoPET imaging agents for the diagnosis of cancer

Stacey Erin Rudd

Thesis / Dissertation  |  2018

Positron emission tomography (PET) is a medical diagnostic imaging technique that is particularly useful in cancer diagnostics. In..

Copper, gallium and zirconium positron emission tomography imaging agents: The importance of metal ion speciation

Lachlan E McInnes, Stacey E Rudd, Paul S Donnelly

Journal article  |  2017  |  COORDINATION CHEMISTRY REVIEWS

Positron emission tomography (PET) is a medical diagnostic imaging technique that requires administration of a β+-emitting radiotr..

In Vitro and In Vivo Evaluation of Zr-89-DS-8273a as a Theranostic for Anti-Death Receptor 5 Therapy

Ingrid JG Burvenich, Fook-Thean Lee, Nancy Guo, Hui K Gan, Angela Rigopoulos, Adam C Parslow, Graeme J O'Keefe, Sylvia J Gong, Henri Tochon-Danguy, Stacey E Rudd, Paul S Dormelly, Masakatsu Kotsuma, Toshiaki Ohtsuka, Giorgio Senaldi, Andrew M Scott

Journal article  |  2016  |  THERANOSTICS

Background: DS-8273a, an anti-human death receptor 5 (DR5) agonistic antibody, has cytotoxic activity against human cancer cells a..

A desferrioxamine B squaramide ester for the incorporation of zirconium-89 into antibodies

Stacey E Rudd, Peter Roselt, Carleen Cullinane, Rodney J Hicks, Paul S Donnelly

Journal article  |  2016  |  CHEMICAL COMMUNICATIONS

A squaramide ester derivative of desferrioxamine B (H3DFO) that is compatible with aqueous solvents and does not induce antibody a..